Publication:
The relationship between gamma-glutamyl transferase levels and the clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

dc.contributor.authorGul, Mehmet
dc.contributor.authorUyarel, Huseyin
dc.contributor.authorErgelen, Mehmet
dc.contributor.authorEkmekci, Ahmet
dc.contributor.authorOzal, Ender
dc.contributor.authorMurat, Ahmet
dc.contributor.authorKul, Seref
dc.contributor.authorCelik, Omer
dc.contributor.authorKaraca, Gurkan
dc.contributor.authorAkturk, Faruk
dc.contributor.authorEksik, Abdurrahman
dc.date.accessioned2020-10-22T15:52:06Z
dc.date.available2020-10-22T15:52:06Z
dc.date.issued2013-06-01T00:00:00Z
dc.description.abstractObjectives Serum gamma-glutamyl transferase (GGT) activity has been shown to be related to the development of atherosclerosis and cardiovascular events. The aim of this study was to evaluate the prognostic value of GGT in patients with ST-segment elevation myocardial infarction (STEMI) undergoing a primary percutaneous coronary intervention (PCI).
dc.identifier.citationGul M., Uyarel H., Ergelen M., Ekmekci A., Ozal E., Murat A., Kul S., Celik O., Karaca G., Akturk F., et al., -The relationship between gamma-glutamyl transferase levels and the clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention-, CORONARY ARTERY DISEASE, cilt.24, ss.272-278, 2013
dc.identifier.doi10.1097/mca.0b013e328360d131
dc.identifier.scopus84877013103
dc.identifier.urihttp://hdl.handle.net/20.500.12645/23532
dc.identifier.wosWOS:000318154600003
dc.titleThe relationship between gamma-glutamyl transferase levels and the clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
dc.typeArticle
dspace.entity.typePublication
local.avesis.id3d62a64e-b4a5-46b9-80d2-3e012b6b9554
local.publication.isinternational1
Files